We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+14.7%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$26.8B
AUM Growth
+$2.91B
(+12%)
Cap. Flow
+$381M
Cap. Flow
% of AUM
1.42%
Top 10 Holdings %
Top 10 Hldgs %
30.26%
Holding
2,338
New
416
Increased
946
Reduced
559
Closed
143
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$80.5M |
| 2 |
Netflix
NFLX
|
+$48M |
| 3 |
Broadcom
AVGO
|
+$47.1M |
| 4 |
Palantir
PLTR
|
+$44.5M |
| 5 |
Intuitive Surgical
ISRG
|
+$41.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$62.2M |
| 2 |
Global Payments
GPN
|
+$50.1M |
| 3 |
Honeywell
HON
|
+$31.1M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$30.5M |
| 5 |
Medtronic
MDT
|
+$30.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.25% |
| 2 | Financials | 14.66% |
| 3 | Consumer Discretionary | 9.77% |
| 4 | Communication Services | 9.36% |
| 5 | Healthcare | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Fluor
FLR
$7.29B
| $1.13M | ﹤0.01% |
22,000
-15,100
| -41% | -$602K |
|
877
Paychex
PAYX
$40.4B
| $1.12M | ﹤0.01% |
+7,713
| New | +$1.16M |
|
878
InterDigital
IDCC
$6.68B
| $1.12M | ﹤0.01% |
5,000
+300
| +6% | +$63.6K |
|
879
Under Armour
UAA
$3B
| $1.11M | ﹤0.01% |
162,598
-25,464
| -14% | -$159K |
|
880
W.W. Grainger
GWW
$65.3B
| $1.1M | ﹤0.01% |
+1,059
| New | +$1.1M |
|
881
Rhythm Pharmaceuticals
RYTM
$7B
| $1.1M | ﹤0.01% |
17,400
-1,100
| -6% | -$67.4K |
|
882
Lumen
LUMN
$6.53B
| $1.1M | ﹤0.01% |
250,800
-23,000
| -8% | -$89.1K |
|
883
Rocket Lab Corp
RKLB
$39.9B
| $1.1M | ﹤0.01% |
30,681
-33,619
| -52% | -$823K |
|
884
Louisiana-Pacific
LPX
$5.2B
| $1.1M | ﹤0.01% |
12,747
-2,902
| -19% | -$258K |
|
885
UiPath
PATH
$5.62B
| $1.1M | ﹤0.01% |
+85,617
| New | +$1.03M |
|
886
ACI Worldwide
ACIW
$5.72B
| $1.09M | ﹤0.01% |
23,800
-4,100
| -15% | -$202K |
|
887
Dorman Products
DORM
$4.01B
| $1.09M | ﹤0.01% |
8,900
+500
| +6% | +$60.8K |
|
888
Loar Holdings
LOAR
$6.64B
| $1.09M | ﹤0.01% |
12,652
-1,728
| -12% | -$150K |
|
889
Norwegian Cruise Line
NCLH
$8.89B
| $1.09M | ﹤0.01% |
53,534
+6,307
| +13% | +$113K |
|
890
Calix
CALX
$2.27B
| $1.09M | ﹤0.01% |
20,400
-3,600
| -15% | -$154K |
|
891
Shift4
FOUR
$3.84B
| $1.08M | ﹤0.01% |
10,946
-430
| -4% | -$37.5K |
|
892
Rivian
RIVN
$22.9B
| $1.08M | ﹤0.01% |
78,878
-15,922
| -17% | -$216K |
|
893
Protagonist Therapeutics
PTGX
$8.75B
| $1.08M | ﹤0.01% |
19,600
+600
| +3% | +$28.8K |
|
894
SiteOne Landscape Supply
SITE
$4.43B
| $1.07M | ﹤0.01% |
8,883
+1,442
| +19% | +$170K |
|
|
OKLO
895
Oklo
OKLO
$7B
| $1.07M | ﹤0.01% |
+19,100
| New | +$737K |
|
896
Concentrix
CNXC
$1.36B
| $1.07M | ﹤0.01% |
+20,232
| New | +$1.07M |
|
897
Brinker International
EAT
$8.02B
| $1.06M | ﹤0.01% |
5,900
+1,200
| +26% | +$188K |
|
|
BPMC
898
DELISTED
Blueprint Medicines
BPMC
| $1.06M | ﹤0.01% |
8,300
+1,600
| +24% | +$166K |
|
899
Guardant Health
GH
$19.5B
| $1.06M | ﹤0.01% |
20,400
+1,400
| +7% | +$62.5K |
|
900
Qualys
QLYS
$4.84B
| $1.06M | ﹤0.01% |
7,400
+4,100
| +124% | +$543K |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q2 2025 Portfolio in Review
As of Q2 2025, STRS Ohio held 2,338 positions worth $26.8B, up 12% from $23.9B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
STRS Ohio's Q2 2025 filing shows 416 new, 946 increased, 559 reduced and 143 closed positions. Its largest new stake was Rockwell Automation: 97,205 shares worth $32.3M. The largest sale was Progressive, an estimated $62.2M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
- STRS Ohio's largest Q2 2025 buy was Rockwell Automation: 97,205 shares worth $32.3M.
- STRS Ohio added most to Microsoft in Q2 2025, an estimated $80.5M increase.
- STRS Ohio's biggest Q2 2025 reduction was Progressive, cutting an estimated $62.2M.
- STRS Ohio fully exited AstraZeneca in Q2 2025, selling an estimated $26.8M.
- STRS Ohio's ten largest holdings make up 30% of its $26.8B portfolio in Q2 2025.
- STRS Ohio opened 416 new positions and closed 143 in Q2 2025.
- STRS Ohio's portfolio value rose 12% quarter-over-quarter to $26.8B.
Based on STRS Ohio's 13F filing for Q2 2025, filed 4 Aug 2025.